| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8682841 | Clinical Neurophysiology | 2018 | 29 Pages |
Abstract
These results suggest that α2a adrenergic agonists may be developed as a new class of sleep enhancing medications with neurocognitive sparing benefits.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Oluwaseun Akeju, Lauren E. Hobbs, Lei Gao, Sara M. Burns, Kara J. Pavone, George S. Plummer, Elisa C. Walsh, Tim T. Houle, Seong-Eun Kim, Matt T. Bianchi, Jeffrey M. Ellenbogen, Emery N. Brown,